Back to Search
MICHAEL CLOUSER, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1801883400Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
11507(OK)
Research & Publications (5)
Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
PMID 19226541·Pharmacoepidemiol Drug Saf·2009
4-observational
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
PMID 18314182·Gynecol Oncol·2008
3-trial
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200).
PMID 17949799·Gynecol Oncol·2008
4-observational
Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression.
PMID 17119060·Cancer Epidemiol Biomarkers Prev·2006
8-other
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
PMID 15928305·J Natl Cancer Inst·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5801 E 41ST ST STE 900
TULSA, OK 74135 - Phone
- (918) 747-4975
Quick Facts
- NPI
- 1801883400
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile